Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Nilufar Partovi"'
Autor:
Ip Stephen, Trana Hussaini, Aliya Daulat, Nilufar Partovi, Siegfried R. Erb, Eric M. Yoshida, Vladimir Marquez
Publikováno v:
Annals of Hepatology, Vol 16, Iss 2, Pp 230-235 (2017)
Background. Chronic renal failure (CRF) is a significant cause of morbidity and mortality in post-liver transplantation (LT) recipients. The risk factors associated with the development of renal dysfunction are not clearly elucidated. Objectives. To
Externí odkaz:
https://doaj.org/article/a80a83fb6e054364ac6c909492fc9103
Autor:
Erin Ready, Kseniya Chernushkin, Nilufar Partovi, Trana Hussaini, Cindy Luo, Olwyn Johnston, R. Jean Shapiro
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 5 (2018)
Background: Posttransplant lymphoproliferative disorder (PTLD) is a major complication following kidney transplantation. Objective: We undertook this study to characterize PTLD in kidney transplant patients in British Columbia with regard to incidenc
Externí odkaz:
https://doaj.org/article/0268481d62f34427b1af08cda9b64245
Autor:
Anna Maruyama, Trana Hussaini, Nilufar Partovi, Siegfried R. Erb, Vladimir Marquez Azalgara, Nadia Zalunardo, Neora Pick, Mark Hull, Eric M. Yoshida
Publikováno v:
Canadian Journal of Infectious Diseases and Medical Microbiology, Vol 2016 (2016)
Although major advances have occurred in treating patients with hepatitis C virus (HCV) with the development of new direct-acting antivirals (DAAs), treatment of liver transplant recipients with HCV, human immunodeficiency virus (HIV) coinfection, an
Externí odkaz:
https://doaj.org/article/f38d6d8edd744d8cb88ea7c6e2b6502a
Publikováno v:
Annals of Hepatology, Vol 11, Iss 2, Pp 179-185 (2012)
Purpose. Chronic hepatitis C virus (HCV) is a major problem affecting up to 170 million people worldwide. Two protease inhibitors have recently been approved that will revolutionize treatment. Our objective was to summarize and evaluate the literatur
Externí odkaz:
https://doaj.org/article/59ae163287cc4f1e8a19d164a019b7cb
Publikováno v:
Canadian Journal of Gastroenterology, Vol 26, Iss 4, Pp 205-210 (2012)
OBJECTIVE: To summarize and evaluate the published literature pertaining to boceprevir and telaprevir, and to provide clinicians with suggestions for use in patients with chronic hepatitis C infection.
Externí odkaz:
https://doaj.org/article/2368136db89d419ea5d94a767f58731b
Autor:
Erica D Greanya, Nilufar Partovi, Eric M Yoshida, R Jean Shapiro, Robert D Levy, Chris H Sherlock, Gwen M Stephens
Publikováno v:
Canadian Journal of Infectious Diseases and Medical Microbiology, Vol 16, Iss 6, Pp 335-341 (2005)
BACKGROUND: The pp65 cytomegalovirus (CMV) antigenemia assay has been used as a means of guiding the pre-emptive therapy of CMV disease in solid organ transplant (SOT) recipients. Recently, concerns have been raised regarding the utility of the test
Externí odkaz:
https://doaj.org/article/2068f9b6c2b341d29bfd13e18fc6f704
Autor:
Eric M Yoshida, Christopher R Shackleton, Siegfried R Erb, Charles H Scudamore, Lynn M Mori Rn, Jo-Ann E Ford, Heather Eggen, Victoria Wynn, Nilufar Partovi, Paul A Keown
Publikováno v:
Canadian Journal of Gastroenterology, Vol 10, Iss 6, Pp 376-380 (1996)
To study the effect of immunosuppressive reduction on the incidence and consequence of late acute rejection (LAR) in liver allograft recipients, mean daily prednisone dose, mean cyclosporine A (CsA) trough and nadir levels were retrospectively review
Externí odkaz:
https://doaj.org/article/068f26e9cc844a488cf51ea76a706b72
Publikováno v:
Canadian Journal of Gastroenterology, Vol 20, Iss 8, Pp 519-520 (2006)
Externí odkaz:
https://doaj.org/article/e528cfdb7a8844a8b83d77cfbef0f287
Autor:
Jennifer Grant, Salomeh Shajari, Bassam A. Masri, Andrew T. Meikle, Raymond H. Mak, Tim T Y Lau, Wendy H.C. Song, Nilufar Partovi
Publikováno v:
Surgery. 170:783-789
Background Cefazolin surgical prophylaxis is associated with better patient outcomes; however, its use in penicillin-allergic patients is controversial. We evaluated the safety of cefazolin as surgical prophylaxis in penicillin-allergic patients, inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67df023da1431d8a65ac9c22bd124a54
https://doi.org/10.1016/j.surg.2021.03.022
https://doi.org/10.1016/j.surg.2021.03.022
Publikováno v:
Can J Hosp Pharm
Background: The expanded scope of pharmacist practice allows for increased comprehensive care and improved patient outcomes at the cost of increased workload and time demands on pharmacists. There are limited descriptive metrics for the time that pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b030ccc604196e2f17f4bcef58b8748
https://doi.org/10.4212/cjhp.v73i4.3026
https://doi.org/10.4212/cjhp.v73i4.3026